TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma

The present study was the first comprehensive investigation of genetic mutation and expression levels of the p53 signaling genes in cutaneous melanoma through various genetic databases providing large datasets. The mutational landscape of p53 and its signaling genes was higher than expected, with TP...

Full description

Bibliographic Details
Main Authors: Safir Ullah Khan, Zahid Ullah, Hadia Shaukat, Shiza Unab, Saba Jannat, Waqar Ali, Amir Ali, Muhammad Irfan, Muhammad Fiaz Khan, Rodolfo Daniel Cervantes-Villagrana
Format: Article
Language:English
Published: SAGE Publishing 2023-08-01
Series:Cancer Informatics
Online Access:https://doi.org/10.1177/11769351231177267
_version_ 1797687468247482368
author Safir Ullah Khan
Zahid Ullah
Hadia Shaukat
Shiza Unab
Saba Jannat
Waqar Ali
Amir Ali
Muhammad Irfan
Muhammad Fiaz Khan
Rodolfo Daniel Cervantes-Villagrana
author_facet Safir Ullah Khan
Zahid Ullah
Hadia Shaukat
Shiza Unab
Saba Jannat
Waqar Ali
Amir Ali
Muhammad Irfan
Muhammad Fiaz Khan
Rodolfo Daniel Cervantes-Villagrana
author_sort Safir Ullah Khan
collection DOAJ
description The present study was the first comprehensive investigation of genetic mutation and expression levels of the p53 signaling genes in cutaneous melanoma through various genetic databases providing large datasets. The mutational landscape of p53 and its signaling genes was higher than expected, with TP53 followed by CDKN2A being the most mutated gene in cutaneous melanoma. Furthermore, the expression analysis showed that TP53 , MDM2 , CDKN2A , and TP53BP1 were overexpressed, while MDM4 and CDKN2B were under-expressed in cutaneous melanoma. Overall, TCGA data revealed that among all the other p53 signaling proteins, CDKN2A was significantly higher in both sun and non-sun-exposed healthy tissues than in melanoma. Likewise, MDM4 and TP53BP1 expressions were markedly greater in non-sun-exposed healthy tissues compared to other groups. However, CDKN2B expression was higher in the sun-exposed healthy tissues than in other tissues. In addition, various genes were expressed significantly differently among males and females. In addition, CDKN2A was highly expressed in the SK-MEL-30 skin cancer cell line, whereas, Immune cell type expression analysis revealed that the MDM4 was highly expressed in naïve B-cells. Furthermore, all six genes were significantly overexpressed in extraordinarily overweight or obese tumor tissues compared to healthy tissues. MDM2 expression and tumor stage were closely related. There were differences in gene expression across patient age groups and positive nodal status. TP53 showed a positive correlation with B cells, MDM2 with CD8+ T cells, macrophages and neutrophils, and MDM4 with neutrophils. CDKN2A/B had a non-significant correlation with all six types of immune cells. However, TP53BP1 was positively correlated with all five types of immune cells except B cells. Only TP53, MDM2 , and CDKN2A had a role in cutaneous melanoma-specific tumor immunity. All TP53 and its regulating genes may be predictive for prognosis. The results of the present study need to be validated through future screening, in vivo, and in vitro studies.
first_indexed 2024-03-12T01:19:26Z
format Article
id doaj.art-4b4dcebd0d5c4bc9bf4e59b44d849741
institution Directory Open Access Journal
issn 1176-9351
language English
last_indexed 2024-03-12T01:19:26Z
publishDate 2023-08-01
publisher SAGE Publishing
record_format Article
series Cancer Informatics
spelling doaj.art-4b4dcebd0d5c4bc9bf4e59b44d8497412023-09-13T08:33:21ZengSAGE PublishingCancer Informatics1176-93512023-08-012210.1177/11769351231177267TP53 and its Regulatory Genes as Prognosis of Cutaneous MelanomaSafir Ullah Khan0Zahid Ullah1Hadia Shaukat2Shiza Unab3Saba Jannat4Waqar Ali5Amir Ali6Muhammad Irfan7Muhammad Fiaz Khan8Rodolfo Daniel Cervantes-Villagrana9Department of Cell Biology, Center for Research and Advanced Studies, National Polytechnic Institute, Mexico City, MexicoDepartment of Software Engineering, Abasyn University Peshawar, Peshawar, PakistanDepartment of Zoology, Women University of Swabi, Swabi, Khyber Pakhtunkhwa, PakistanDepartment of Zoology, University of Mianwali, Mianwali, PakistanDepartment of Zoology, Women University of Swabi, Swabi, Khyber Pakhtunkhwa, PakistanBiochemical and Biotechnological Sciences Università degli studi della Campania Luigi Vanvitelli, Caserta, Campania, ItalyNanosciences and Nanotechnology Program, Center for Research and Advanced Studies, National Polytechnic Institute, Mexico City, MexicoDepartment of Zoology, Wildlife and Fisheries, Pir Mehr Ali Shah Arid Agriculture University Rawalpindi, Punjab, PakistanDepartment of Zoology, Hazara University, Mansehra, PakistanDepartment of Pharmacology, Center for Research and Advanced Studies, National Polytechnic Institute, Mexico City, MexicoThe present study was the first comprehensive investigation of genetic mutation and expression levels of the p53 signaling genes in cutaneous melanoma through various genetic databases providing large datasets. The mutational landscape of p53 and its signaling genes was higher than expected, with TP53 followed by CDKN2A being the most mutated gene in cutaneous melanoma. Furthermore, the expression analysis showed that TP53 , MDM2 , CDKN2A , and TP53BP1 were overexpressed, while MDM4 and CDKN2B were under-expressed in cutaneous melanoma. Overall, TCGA data revealed that among all the other p53 signaling proteins, CDKN2A was significantly higher in both sun and non-sun-exposed healthy tissues than in melanoma. Likewise, MDM4 and TP53BP1 expressions were markedly greater in non-sun-exposed healthy tissues compared to other groups. However, CDKN2B expression was higher in the sun-exposed healthy tissues than in other tissues. In addition, various genes were expressed significantly differently among males and females. In addition, CDKN2A was highly expressed in the SK-MEL-30 skin cancer cell line, whereas, Immune cell type expression analysis revealed that the MDM4 was highly expressed in naïve B-cells. Furthermore, all six genes were significantly overexpressed in extraordinarily overweight or obese tumor tissues compared to healthy tissues. MDM2 expression and tumor stage were closely related. There were differences in gene expression across patient age groups and positive nodal status. TP53 showed a positive correlation with B cells, MDM2 with CD8+ T cells, macrophages and neutrophils, and MDM4 with neutrophils. CDKN2A/B had a non-significant correlation with all six types of immune cells. However, TP53BP1 was positively correlated with all five types of immune cells except B cells. Only TP53, MDM2 , and CDKN2A had a role in cutaneous melanoma-specific tumor immunity. All TP53 and its regulating genes may be predictive for prognosis. The results of the present study need to be validated through future screening, in vivo, and in vitro studies.https://doi.org/10.1177/11769351231177267
spellingShingle Safir Ullah Khan
Zahid Ullah
Hadia Shaukat
Shiza Unab
Saba Jannat
Waqar Ali
Amir Ali
Muhammad Irfan
Muhammad Fiaz Khan
Rodolfo Daniel Cervantes-Villagrana
TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma
Cancer Informatics
title TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma
title_full TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma
title_fullStr TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma
title_full_unstemmed TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma
title_short TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma
title_sort tp53 and its regulatory genes as prognosis of cutaneous melanoma
url https://doi.org/10.1177/11769351231177267
work_keys_str_mv AT safirullahkhan tp53anditsregulatorygenesasprognosisofcutaneousmelanoma
AT zahidullah tp53anditsregulatorygenesasprognosisofcutaneousmelanoma
AT hadiashaukat tp53anditsregulatorygenesasprognosisofcutaneousmelanoma
AT shizaunab tp53anditsregulatorygenesasprognosisofcutaneousmelanoma
AT sabajannat tp53anditsregulatorygenesasprognosisofcutaneousmelanoma
AT waqarali tp53anditsregulatorygenesasprognosisofcutaneousmelanoma
AT amirali tp53anditsregulatorygenesasprognosisofcutaneousmelanoma
AT muhammadirfan tp53anditsregulatorygenesasprognosisofcutaneousmelanoma
AT muhammadfiazkhan tp53anditsregulatorygenesasprognosisofcutaneousmelanoma
AT rodolfodanielcervantesvillagrana tp53anditsregulatorygenesasprognosisofcutaneousmelanoma